FT Options’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$147K Sell
45,101
-13,306
-23% -$179K 0.22% 82
2017
Q2
$1.1M Sell
58,407
-25,340
-30% -$353K 1.9% 15
2017
Q1
$1.03M Sell
83,747
-34,726
-29% -$506K 1.35% 18
2016
Q4
$1.88M Sell
118,473
-20,612
-15% -$345K 2.16% 11
2016
Q3
$2.53M Sell
139,085
-53,700
-28% -$878K 2.01% 10
2016
Q2
$3.06M Buy
192,785
+36,348
+23% +$542K 2.63% 7
2016
Q1
$2.33M Buy
+156,437
New +$2.46M 2.44% 7

Other funds holding OTIC

FT Options's OTIC Position: Q3 2017 in Review

FT Options reduced its Otonomy, Inc. (OTIC) stake by 23% in Q3 2017, selling an estimated $179K and leaving 45,101 shares worth $147K. The position accounts for 0.22% of the portfolio, ranked #82.

FT Options first reported a position in OTIC in Q1 2016 and has held it in 7 quarters since. The position peaked at $3.06M in Q2 2016. 84 funds tracked by Wall St. Rank hold OTIC as of Q3 2017.

  • FT Options held 45,101 shares of Otonomy, Inc. worth $147K as of Q3 2017.
  • FT Options sold 13,306 Otonomy, Inc. shares in Q3 2017, an estimated $179K.
  • Otonomy, Inc. made up 0.22% of FT Options's portfolio in Q3 2017, its #82 holding.
  • FT Options first reported a position in Otonomy, Inc. in Q1 2016 and has held it in 7 quarters since.
  • FT Options's Otonomy, Inc. position peaked at $3.06M in Q2 2016.
  • 84 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.